Qing Lin
32Patents
10h-index
56Co-inventors
78Inventor score
Filing activity: May 23, 2002 → Jan 23, 2025
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8685435B2 | Extended release biodegradable ocular implants | Human Necessities | 43 | Active |
| US7262276B2 | Anti human ovarian cancer-anti CD3 bispecific antibody | Chemistry; Metallurgy | 41 | Expired |
| US8759295B2 | Peptide-peptidase inhibitor conjugates and methods of using same | Human Necessities | 32 | Active |
| US8753709B2 | Methods of forming coatings with a crystalline or partially crystalline drug for implantable medical devices | Human Necessities | 32 | Active |
| US7985441B1 | Purification of polymers for coating applications | Human Necessities | 24 | Active |
| US8114958B2 | Amylin family peptides | Human Necessities | 23 | Active |
| US8598120B2 | Methods for treatment using amylin family peptides | Human Necessities | 15 | Active |
| US8302257B2 | Double-pedal double-wheel truckle with independent braking and releasing functions | Performing Operations; Transporting | 11 | Active |
| US8551512B2 | Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS | Human Necessities | 11 | Active |
| USD573010S1 | Double-pedal double wheel caster | General | 10 | Expired |
| US9038786B2 | Multifunctional castor | Performing Operations; Transporting | 6 | Active |
| US10874605B2 | Extended release biodegradable ocular implants | Human Necessities | 5 | Active |
| US8586707B2 | Stapled peptides and method of synthesis | Chemistry; Metallurgy | 4 | Active |
| US9814553B1 | Bioabsorbable semi-crystalline polymer for controlling release of drug from a coating | Human Necessities | 3 | Active |
| US9038785B2 | Castor with separate brake device and brake release device | Performing Operations; Transporting | 3 | Active |
| US8974812B2 | Extended release biodegradable ocular implants | Human Necessities | 3 | Active |
| US11694292B2 | Soft segmentation based rules optimization for zero detection loss false positive reduction | Physics | 3 | Active |
| US10131768B2 | Liquid (meth)acrylic syrup for impregnating a fibrous substrate, method of impregnating a fibrous substrate, composite material obtained following polymerisation of the pre-impregnated substrate | Chemistry; Metallurgy | 3 | Active |
| US8598314B2 | Peptide-peptidase-inhibitor conjugates and methods of making and using same | Human Necessities | 2 | Active |
| US10676537B2 | Antibody targeted to tissue factor, preparation method therefor, and use thereof | Physics | 2 | Active |
| US9931379B2 | Oxyntomodulin analogs and methods of making and using same | Human Necessities | 1 | Active |
| US11534495B2 | Tissue factor-targeted antibody-drug conjugate | Chemistry; Metallurgy | 1 | Active |
| US8895049B2 | Extended release biodegradable ocular implants | Human Necessities | 1 | Active |
| US10945993B2 | Methods of recruiting SDF-producing macrophages | Human Necessities | 0 | Active |
| US10154960B2 | Extended release biodegradable ocular implants | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.